Heart failure with a normal ejection fraction

This source preferred by Stephen Allen

Authors: Ooi, M. and Allen, S.C.

http://www.rila.co.uk/site/modules.php?name=Journals&file=journal2&func=showab&jid=005&aid=5387&iid=456

Journal: CME Geriatric Medicine

Volume: 10

Pages: 72-75

ISSN: 1475-1453

Heart failure with a normal left ventricular ejection fraction (HFNEF) is a significant cause of mortality and morbidity in older people, particularly women with hypertension. This clinical syndrome remains under-recognised despite its prevalence and the long-term prognosis remains poor. HFNEF has emerged in the last 10-15 years as a distinct clinical and patho-physiological entity that has been recognised in the 2005 revised guidelines for the diagnosis and treatment of chronic heart failure, of the European Society of Cardiology, and American Heart Association/American College of Cardiology. However, there is currently no proven specific therapy for heart failure with a well-preserved left ventricular ejection fraction largely due to a lack of evidence-based information on therapeutic intervention. This review examines the clinical and physiological characteristics of HFNEF and weighs up the management options available.

This data was imported from Scopus:

Authors: Ooi, M. and Allen, S.C.

Journal: CME Journal Geriatric Medicine

Volume: 10

Issue: 2

Pages: 72-75

ISSN: 1475-1453

Heart failure with a normal left ventricular ejection fraction (HFNEF) is a significant cause of mortality and morbidity in older people, particularly women with hypertension. This clinical syndrome remains under-recognised despite its prevalence and the long-term prognosis remains poor. HFNEF has emerged in the last 10-15 years as a distinct clinical and patho-physiological entity that has been recognised in the 2005 revised guidelines for the diagnosis and treatment of chronic heart failure, of the European Society of Cardiology, and American Heart Association/American College of Cardiology. However, there is currently no proven specific therapy for heart failure with a well-preserved left ventricular ejection fraction largely due to a lack of evidence-based information on therapeutic intervention. This review examines the clinical and physiological characteristics of HFNEF and weighs up the management options available. © 2008 Rila Publications Ltd.

The data on this page was last updated at 04:58 on April 25, 2019.